Stock Quality:
Last 7 days
3.2%
Last 30 days
-11.0%
Last 90 days
3.2%
Trailing 12 Months
-44.9%
ANTX RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 94.0K | 307.0K | 748.0K | 1.4M |
2021 | 0 | 0 | 0 | 69.0K |
CEO | Mr. Eric E. Easom |
---|---|
WEBSITE | an2therapeutics.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 35 |